Assignee
SpecGx LLC
US15 patents
Top patents by PatentIndex Score
US11077024B2Aug 3, 2021
Systems and methods for high humidity curing within tablet coating system
SpecGx LLC2 citations65
US11033508B2Jun 15, 2021
Delayed sustained release pharmaceutical compositions
SpecGx LLC2 citations63
US11065246B2Jul 20, 2021
Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties
SpecGx LLC0 citations59
US11096887B2Aug 24, 2021
Extended release, abuse deterrent pharmaceutical compositions
SpecGx LLC0 citations57
US12371423B2Jul 29, 2025
Preparation of sufentanil citrate and sufentanil base
SpecGx LLC0 citations56
US12208094B2Jan 28, 2025
Extended release, abuse deterrent dosage forms
SpecGx LLC0 citations56
US11617712B2Apr 4, 2023
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
SpecGx LLC0 citations56
US11583493B2Feb 21, 2023
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
SpecGx LLC0 citations56
US11517521B2Dec 6, 2022
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
SpecGx LLC0 citations56
US11446293B2Sep 20, 2022
Extended release, abuse deterrent dosage forms
SpecGx LLC0 citations56
US10899749B2Jan 26, 2021
Preparation of sufentanil citrate and sufentanil base
SpecGx LLC0 citations56
US11666509B2Jun 6, 2023
Systems and methods for high humidity curing within tablet coating system
SpecGx LLC0 citations54
US11464741B2Oct 11, 2022
Spray dried compositions having different dissolution profiles and processes for their preparation
SpecGx LLC0 citations54
US10927068B2Feb 23, 2021
Process for preparing acylated amphetamine derivatives
SpecGx LLC1 citations53
US11478426B2Oct 25, 2022
Abuse deterrent immediate release capsule dosage forms
SpecGx LLC0 citations46